| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3082ea21b9dc6e81f0425279c19ee7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10 |
| filingDate |
1992-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b369197fad5be46bc5940982f50e1689 |
| publicationDate |
1993-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5215973-A |
| titleOfInvention |
Optically active and racemic hydrated diacetylesters of α-glycero-phosphoryl-choline |
| abstract |
Monohydrate 1,2-di-O-acetyl-glycero-phosphoryl-choline in optically active and racemic form, processes for their preparation and pharmaceutical compositions containing them as the active principle for treating cerebral involutions of the aged and for treating dislipidemia and hyperlipoproteinemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108101937-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108101937-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10259834-B2 |
| priorityDate |
1991-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |